on AFYREN (EPA:ALAFY)
AFYREN presents annual financial results for 2024
Greentech company AFYREN has presented its financial results for 2024, with targets for continuous production starting in 2025. In collaboration with AFYREN NEOXY, the production and marketing of several tons of its flagship bioproduct, bio-sourced acids, have been intensified. The quality of the products has been validated by customers in demanding sectors such as food and flavors.
Financially, the net loss remained stable compared to 2023, standing at €9.75 million. Cash position decreased but remains solid at €33.5 million. AFYREN relied on non-dilutive financing to support AFYREN NEOXY.
For the coming years, an important milestone will be reaching profitability and expanding its production internationally, particularly in Asia.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news